• +1-646-491-9876
    • +91-20-67278686

    Search

    Arterial Thrombosis - Pipeline Review, H1 2017

    Arterial Thrombosis - Pipeline Review, H1 2017

    • Report Code ID: RW0001709422
    • Category Pharmaceuticals
    • No. of Pages 45
    • Publication Month Mar-17
    • Publisher Name Global Markets Direct
    Arterial Thrombosis - Pipeline Review, H1 2017

    Summary

    Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Arterial Thrombosis - Pipeline Review, H1 2017, provides an overview of the Arterial Thrombosis (Cardiovascular) pipeline landscape.

    Arterial thrombosis is a blood clot that develops in an artery. Symptoms include lack of pulse, pain or spasms in the muscles, pale skin and coldness. Depending on where the clot forms, arterial thrombosis can cause several serious conditions, including stroke, heart attack and peripheral arterial disease (PAD) . Predisposing factors include smoking, obesity, diabetes, hypertension and high cholesterol level. Treatment includes thrombolytic agents and surgery.

    Report Highlights

    Publisher's Pharmaceutical and Healthcare latest pipeline guide Arterial Thrombosis - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Arterial Thrombosis (Cardiovascular) , complete with analysis by stage of development, drug target, mechanism of action (MoA) , route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

    The Arterial Thrombosis (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Arterial Thrombosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, Preclinical and Discovery stages are 1, 3, 7 and 1 respectively. Similarly, the Universities portfolio in Phase II and Preclinical stages comprises 1 and 4 molecules, respectively.

    Arterial Thrombosis (Cardiovascular) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

    Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

    Scope

    - The pipeline guide provides a snapshot of the global therapeutic landscape of Arterial Thrombosis (Cardiovascular) .
    - The pipeline guide reviews pipeline therapeutics for Arterial Thrombosis (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.
    - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
    - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
    - The pipeline guide reviews key companies involved in Arterial Thrombosis (Cardiovascular) therapeutics and enlists all their major and minor projects.
    - The pipeline guide evaluates Arterial Thrombosis (Cardiovascular) therapeutics based on mechanism of action (MoA) , drug target, route of administration (RoA) and molecule type.
    - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
    - The pipeline guide reviews latest news related to pipeline therapeutics for Arterial Thrombosis (Cardiovascular)

    Reasons to buy

    - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
    - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
    - Find and recognize significant and varied types of therapeutics under development for Arterial Thrombosis (Cardiovascular) .
    - Classify potential new clients or partners in the target demographic.
    - Develop tactical initiatives by understanding the focus areas of leading companies.
    - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
    - Formulate corrective measures for pipeline projects by understanding Arterial Thrombosis (Cardiovascular) pipeline depth and focus of Indication therapeutics.
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
    - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
    Table of Contents
    List of Tables
    List of Figures
    Introduction
    Publisher Report Coverage
    Arterial Thrombosis - Overview
    Arterial Thrombosis - Therapeutics Development
    Pipeline Overview
    Pipeline by Companies
    Pipeline by Universities/Institutes
    Products under Development by Companies
    Products under Development by Universities/Institutes
    Arterial Thrombosis - Therapeutics Assessment
    Assessment by Target
    Assessment by Mechanism of Action
    Assessment by Route of Administration
    Assessment by Molecule Type
    Arterial Thrombosis - Companies Involved in Therapeutics Development
    Astellas Pharma Inc
    Bayer AG
    Bristol-Myers Squibb Company
    Eisai Co Ltd
    Johnson & Johnson
    Sanofi
    Thromboserin Ltd
    Arterial Thrombosis - Drug Profiles
    AB-002 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    AS-1468240 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    ASP-6537 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    BAY-1213790 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    BMS-654457 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    BMS-884775 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    BMS-986120 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    C-3 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    E-5539 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    ER-410660 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    JNJ-375 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Peptide to Inhibit PAI-1 for Arterial Thrombosis and Pulmonary Thromboembolism - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    PZ-128 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Recombinant Protein to Antagonize ITGA2B and ITGB3 for Arterial Thrombosis and Ischemic Cerebral Stroke - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    SAR-216471 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Small Molecule to Inhibit Integrin alpha 2 beta 1 for Arterial Thrombosis - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    THL-001 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Arterial Thrombosis - Dormant Projects
    Appendix
    Methodology
    Coverage
    Secondary Research
    Primary Research
    Expert Panel Validation
    Contact Us
    Disclaimer

    List of Tables

    Number of Products under Development for Arterial Thrombosis, H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products under Development by Universities/Institutes, H1 2017
    Products under Development by Companies, H1 2017
    Products under Development by Universities/Institutes, H1 2017
    Number of Products by Stage and Target, H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017
    Number of Products by Stage and Route of Administration, H1 2017
    Number of Products by Stage and Molecule Type, H1 2017
    Arterial Thrombosis - Pipeline by Astellas Pharma Inc, H1 2017
    Arterial Thrombosis - Pipeline by Bayer AG, H1 2017
    Arterial Thrombosis - Pipeline by Bristol-Myers Squibb Company, H1 2017
    Arterial Thrombosis - Pipeline by Eisai Co Ltd, H1 2017
    Arterial Thrombosis - Pipeline by Johnson & Johnson, H1 2017
    Arterial Thrombosis - Pipeline by Sanofi, H1 2017
    Arterial Thrombosis - Pipeline by Thromboserin Ltd, H1 2017
    Arterial Thrombosis - Dormant Projects, H1 2017

    List of Figures

    Number of Products under Development for Arterial Thrombosis, H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products under Development by Universities/Institutes, H1 2017
    Number of Products by Top 10 Targets, H1 2017
    Number of Products by Stage and Top 10 Targets, H1 2017
    Number of Products by Top 10 Mechanism of Actions, H1 2017
    Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
    Number of Products by Routes of Administration, H1 2017
    Number of Products by Stage and Routes of Administration, H1 2017
    Number of Products by Molecule Types, H1 2017
    Number of Products by Stage and Molecule Types, H1 2017
    Astellas Pharma Inc
    Bayer AG
    Bristol-Myers Squibb Company
    Eisai Co Ltd
    Johnson & Johnson
    Sanofi
    Thromboserin Ltd

    Request for Sample

    Report Url http://www.reportsweb.com//arterial-thrombosis-pipeline-review-h1-2017&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url http://www.reportsweb.com//arterial-thrombosis-pipeline-review-h1-2017&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url http://www.reportsweb.com//arterial-thrombosis-pipeline-review-h1-2017&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments